# Ministry of Science and Innovation of Spain

> Ministry of Science and Innovation of Spain is a VC fund backing Biotechnology and Medical. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Madrid, Spain
- Total investments: 7
- Last investment: Feb 2026
- Lead investor: 86%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/cienciagob
- Website: https://www.ciencia.gob.es/en

Ministry of Science and Innovation of Spain is a VC fund in Madrid focused on Biotechnology and Medical. Ministry of Science and Innovation of Spain provides policies for universities, scientific and technical research, technological development

## Round sizes

| Stage | Round size |
| --- | --- |
| Grant | $841k–$2.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 86% |
| Medical | 4 | 57% |
| Health Care | 3 | 43% |
| Therapeutics | 2 | 29% |
| Biopharma | 1 | 14% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 5 | 71% |
| Seed | 1 | 14% |
| Pre-Seed | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Gyala Therapeutics | Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas. |  | Grant | Feb 10, 2026 |  |
| Oniria Therapeutics | Onira Therapeutics is modifying cell dormancy to fight the persistence of cancer. | $2.3M | Grant | May 05, 2025 | https://www.oniriatherapeutics.com |
| Orikine Bio | Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders. | $840.8K | Grant | Dec 03, 2024 | https://www.orikine.bio |
| Biointaxis | Biointaxis is a genomic treatment and technology development company. The current lead program develops a gene therapy treatment for Friedreich ataxia, a rare, inherited, progressive neurodegenerative disease that typically affects teenagers and young adults. They reestablished the neurological functions in mice models of friedreich ataxia. | $2.3M | Grant | Oct 23, 2024 | http://biointaxis.com/ |
| Connecta Therapeutics | Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome. | $2.9M | Seed | Feb 12, 2024 | https://connectatherapeutics.com/ |
| Manina Medtech | Manina medtech manufactures medical solution - seedchrony that calculates the perfect time for IVF treatment. | $1.9M | Pre-Seed | Jan 03, 2024 | https://maninamedtech.com/ |
| OXOlife | Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility treatments Oxolife (was founded in January 2013 by an entrepreneurial and multidisciplinary team formed biochemists and clinical Pharmacologist, with more than 10 year of expertise in R&D and pharmaceutical market. | $2.5M | Grant | Dec 12, 2022 | http://www.oxolife.com/ |

7 of 7 investments shown.

## Co-investors
- [Centre for the Development of Industrial Technology (CDTI)](https://shizune.co/investors/profile/centre-for-the-development-of-industrial-technology-cdti) — VC Fund, 1 deal together
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund, 1 deal together
- [European Commission](https://shizune.co/investors/profile/european-commission) — VC Fund, 1 deal together
- [European Union](https://shizune.co/investors/profile/european-union) — VC Fund, 1 deal together
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund, 1 deal together
- [Medex Partners](https://shizune.co/investors/profile/medex-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Spain](https://shizune.co/investors/medical-vc-funds-spain)
- [Medical Investors in Spain](https://shizune.co/investors/medical-investors-spain)

## FAQ

### What does Ministry of Science and Innovation of Spain invest in?

Ministry of Science and Innovation of Spain invests primarily in Biotechnology, Medical and Health Care startups, most often at Grant and Seed stage. Most of the 7 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Ministry of Science and Innovation of Spain's check size?

Ministry of Science and Innovation of Spain typically joins rounds of $841k–$2.5M at Grant. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ministry of Science and Innovation of Spain participates in.

### When did Ministry of Science and Innovation of Spain last invest?

The most recent investment recorded for Ministry of Science and Innovation of Spain closed in Feb 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co